Valbiotis SA (ALVAL.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALVAL.PA in your mock portfolio yet.
The negative EPS and corresponding negative P/E ratio indicate that Valbiotis SA is currently loss-making and not generating positive net income. Without evidence of improving profitability or clear visibility to break-even, the financial profile remains high risk from an equity holder’s perspective.
The stock’s 13.5% decline over the past month, despite trading modestly above its 200-day moving average, signals short-term negative momentum. The combination of recent price weakness and loss-making fundamentals points to a fragile technical setup.
Alternative data for Valbiotis SA is mixed: web traffic appears meaningful but we lack trend data, hiring activity is flat with zero open roles, and social media presence is small but growing modestly on most platforms. These signals do not yet point to a strong inflection in business momentum but also do not suggest a collapse in interest.
Overall, Valbiotis SA’s profile appears bearish at this time: the company is loss-making, the stock has sold off sharply in the last month, and technicals show only marginal support above the long-term moving average. Alternative data is broadly neutral and does not yet provide a strong counterweight to the weak financial and price signals.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started